×
About 828 results

ALLMedicine™ Allergic Bronchopulmonary Aspergillosis Center

Research & Reviews  275 results

Subcutaneous entomophthoromycosis in an immunocompetent individual: a localised forearm...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716866
BMJ Case Reports; Katari Gopalakrishanan V, Murali M et. al.

Dec 2nd, 2022 - A man in his 80s with no known comorbidities presented with diffuse swelling on the dorsal aspect of his right forearm for 3 months. Clinical features were suggestive of soft tissue sarcoma of the right forearm. A high resolution CT scan of the th...

ABPA sans asthma: an entity to remember.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703309
BMJ Case Reports; Nair AA, Vimala LR et. al.

Nov 26th, 2022 - A male patient in his 20s presented with a cough and a small volume of haemoptysis that lasted a year. He had no other constitutional symptoms and a respiratory examination was suggestive of a consolidation. A chronic infection, such as tuberculos...

Benralizumab in the management of rare primary eosinophilic lung diseases.
https://doi.org/10.2500/aap.2022.43.220056
Allergy and Asthma Proceedings; Griscti Soler D, Bennici A et. al.

Nov 6th, 2022 - Background: Eosinophils have a double-edged role in the human body, being essential in important physiologic functions but whose presence is conspicuous in a variety of diseases characterized by a T2 inflammation phenotype. Eosinophils are exquisi...

High-attenuation mucus in allergic bronchopulmonary aspergillosis.
https://doi.org/10.1136/archdischild-2022-324674
Archives of Disease in Childhood; Ayub II, Venkatramanan P

Oct 13th, 2022 - High-attenuation mucus in allergic bronchopulmonary aspergillosis.|2022|Ayub II,Venkatramanan P,|

A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
https://clinicaltrials.gov/ct2/show/NCT02440009

Oct 7th, 2022 - The management of allergic bronchopulmonary aspergillosis (ABPA) includes two important aspects namely institution of immunosuppressive therapy in the form of glucocorticoids to control the immunologic activity, and close monitoring for detection ...

see more →

Drugs  15 results see all →

Clinicaltrials.gov  26 results

A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
https://clinicaltrials.gov/ct2/show/NCT02440009

Oct 7th, 2022 - The management of allergic bronchopulmonary aspergillosis (ABPA) includes two important aspects namely institution of immunosuppressive therapy in the form of glucocorticoids to control the immunologic activity, and close monitoring for detection ...

Deflazacort vs. Prednisolone in Acute-stage ABPA
https://clinicaltrials.gov/ct2/show/NCT04227483

Oct 6th, 2022 - Depending on the host immunity and the organism virulence, the respiratory diseases caused by Aspergillus are classified as saprophytic (aspergilloma), allergic (allergic aspergillus sinusitis and allergic bronchopulmonary aspergillosis) and invas...

A Study to Evaluate the Efficacy and Safety of Dupilumab in Participants With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)
https://clinicaltrials.gov/ct2/show/NCT04442269

Sep 6th, 2022 - The primary objective of the study is to evaluate the efficacy of dupilumab on the annualized rate of exacerbations in participants with Allergic Bronchopulmonary Aspergillosis (ABPA). The secondary objectives of the study are: To evaluate the eff...

Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome
https://clinicaltrials.gov/ct2/show/NCT05444946

Jul 6th, 2022 - Aspergillus causes a variety of pulmonary disorders depending on the host immunity. In immunocompetent hosts, it can cause allergic diseases, the prototype being allergic bronchopulmonary aspergillosis (ABPA). In immunosuppressed host, it causes l...

A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pul...
https://clinicaltrials.gov/ct2/show/NCT04824417

Jun 13th, 2022 - Aspergillus is a saprophytic fungus which is present normally in our surroundings and causes a large number of pulmonary diseases spreading through inhalational route. The spectrum of disease caused by aspergillus spp. is wide with the manifestati...

see more →

News  7 results

Five Things You Need to Know About Bronchiectasis
https://www.medscape.com/viewarticle/955069

Jul 22nd, 2021 - Bronchiectasis is a chronic condition characterised by symptoms of persistent or recurrent bronchial sepsis caused by irreversible damage to and dilation of the bronchi.[1] The key principles of the diagnosis and management of bronchiectasis were ...

Fast Five Quiz: How Much Do You Know About Asthma?
https://reference.medscape.com/viewarticle/846001_4

Jun 4th, 2019 - Blood eosinophilia > 4% or 300-400 cells/μL supports the diagnosis of asthma, but the absence of this finding is not exclusionary. Total serum immunoglobulin E levels > 100 IU/mL are frequently observed in patients experiencing allergic reactions,...

Adult bronchiectasis, asthma therapy, frailty in ILD
https://www.mdedge.com/chestphysician/article/158061/society-news/adult-bronchiectasis-asthma-therapy-frailty-ild

Feb 6th, 2018 - Clinical Research New guidelines for adult bronchiectasis Clinically significant bronchiectasis is a combination of radiologic bronchial dilatation with clinical symptoms. Guidelines on management of adult bronchiectasis were recently published (E.

Management of Asthma in the Military
https://www.mdedge.com/fedprac/article/135491/pulmonology/management-asthma-military
Capt Frederic A. Rawlins III, DO, LTC Jacob F. Collen, MD et. al.

Apr 10th, 2017 - Asthma is a chronic inflammatory disorder of the airways that leads to airflow obstruction and bronchial hyperresponsiveness. Clinical features of asthma include episodic cough, wheeze, and dyspnea, which may resolve with avoidance of triggers or.

European societies issue aspergillosis diagnosis, management guidelines
https://www.mdedge.com/chestphysician/article/105429/infectious-diseases/european-societies-issue-aspergillosis-diagnosis
Neil Osterweil, MDedge News

Dec 23rd, 2015 - European respiratory disease and infectious disease specialists have banded together to issue new clinical guidelines on the diagnosis and management of an uncommon but serious problem: chronic pulmonary aspergillosis (CPA). Pulmonary infections w.

see more →

Patient Education  8 results see all →